MedCap AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 241.5 million compared to SEK 202.3 million a year ago. Revenue was SEK 264 million compared to SEK 216 million a year ago. Net income was SEK 36.6 million compared to SEK 26.2 million a year ago. Basic earnings per share was SEK 2.5 compared to SEK 1.8 a year ago. Diluted earnings per share was SEK 2.5 compared to SEK 1.8 a year ago.
For the nine months, sales was SEK 788.5 million compared to SEK 658.4 million a year ago. Revenue was SEK 816 million compared to SEK 676.1 million a year ago. Net income was SEK 77.3 million compared to SEK 55.9 million a year ago. Basic earnings per share was SEK 5.2 compared to SEK 3.8 a year ago. Diluted earnings per share was SEK 5.2 compared to SEK 3.8 a year ago.